Epigenetic Regulation and Nonepigenetic Mechanisms of Ferroptosis Drive Emerging Nanotherapeutics in Tumor
Open Access
- 29 January 2021
- journal article
- review article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2021 (1)
Abstract
Currently, traditional cancer therapy still falls far short of expectations. However, a variety of invasive cancers that are resistant to chemotherapy (such as platinum drugs, one of the most applied antineoplastics in clinic) and targeted agents are susceptible to ferroptosis. Ferroptosis is a form of cell death that is driven by cell metabolism and iron‐dependent lipid peroxidation. Ferroptosis inducers can eliminate the drug resistance of tumor cells in the mesenchymal state, effectively inhibit the drug resistance of acquired tumor cells, and optimize cancer efficacy. Research based on the epigenetic mechanism of ferroptosis is still in the stage of screening and verifying the regulatory effect, and there is no complete regulatory mechanism network. In this review, we expound on the epigenetic regulation and nonepigenetic mechanisms of ferroptosis and review the epigenetic‐based mechanisms of tumor therapy potential and emerging nonepigenetic‐based therapies (nanotherapeutics).Keywords
Funding Information
- National Natural Science Foundation of China (11672197)
This publication has 110 references indexed in Scilit:
- Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in miceNature Cell Biology, 2014
- Regulation of Ferroptotic Cancer Cell Death by GPX4Cell, 2014
- Cancer drug resistance: an evolving paradigmNature Reviews Cancer, 2013
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Dietary Intake and Serum Levels of Iron in Relation to Oxidative Stress in Breast Cancer PatientsJournal of Clinical Biochemistry and Nutrition, 2009
- Mitochondrial Cholesterol Contributes to Chemotherapy Resistance in Hepatocellular CarcinomaCancer Research, 2008
- Synthetic Lethal Screening Identifies Compounds Activating Iron-Dependent, Nonapoptotic Cell Death in Oncogenic-RAS-Harboring Cancer CellsChemistry & Biology, 2008
- Bax activation and stress-induced apoptosis delayed by the accumulation of cholesterol in mitochondrial membranesCell Death & Differentiation, 2007
- RAS–RAF–MEK-dependent oxidative cell death involving voltage-dependent anion channelsNature, 2007
- Strategies for reversing drug resistanceOncogene, 2003